标题
Cancer biomarkers: selecting the right drug for the right patient
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 11, Issue 3, Pages 201-214
出版商
Springer Nature
发表日期
2012-02-10
DOI
10.1038/nrd3651
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).
- (2017) M. G. Kris et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor cells in breast cancer: A tool whose time has come of age
- (2011) Ramona F Swaby et al. BMC Medicine
- Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
- (2011) Gong Tang et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Predictors of Response to Therapy for Breast Cancer
- (2011) Natalie Galanina et al. CANCER JOURNAL
- Circulating Tumors Cells as Biomarkers
- (2011) Daniel C. Danila et al. CANCER JOURNAL
- The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration
- (2011) Kathryn A. Gold et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeting BRAF in Advanced Melanoma: A First Step toward Manageable Disease
- (2011) A. Vultur et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cells as Biomarkers in Prostate Cancer
- (2011) D. C. Danila et al. CLINICAL CANCER RESEARCH
- Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
- (2011) F. Molinari et al. CLINICAL CANCER RESEARCH
- Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib
- (2011) L. Mileshkin et al. CLINICAL CANCER RESEARCH
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography
- (2011) Thomas Zander et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
- (2011) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Accelerated Approval of Oncology Products: The Food and Drug Administration Experience
- (2011) John R. Johnson et al. JNCI-Journal of the National Cancer Institute
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Targeting the missing links for cancer therapy
- (2011) Kornelia Polyak et al. NATURE MEDICINE
- Taming the dragon: genomic biomarkers to individualize the treatment of cancer
- (2011) Ian J Majewski et al. NATURE MEDICINE
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- Integrating predictive biomarkers and classifiers into oncology clinical development programmes
- (2011) Robert A. Beckman et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The BATTLE Trial: A Bold Step toward Improving the Efficiency of Biomarker-Based Drug Development
- (2011) Eric H. Rubin et al. Cancer Discovery
- Biomarker-Driven Early Clinical Trials in Oncology
- (2010) Daniel S. W. Tan et al. CANCER JOURNAL
- The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) L. Seymour et al. CLINICAL CANCER RESEARCH
- The Cross-Validated Adaptive Signature Design
- (2010) B. Freidlin et al. CLINICAL CANCER RESEARCH
- Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
- (2010) J. E. Dancey et al. CLINICAL CANCER RESEARCH
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non-Small Cell Lung Cancer?
- (2010) T. S. Aukema et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application
- (2010) Soo-Youn Lee et al. JOURNAL OF PATHOLOGY
- Comparing Breast Cancer Risk Assessment Models
- (2010) Mitchell H. Gail et al. JNCI-Journal of the National Cancer Institute
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- A policy approach to the development of molecular diagnostic tests
- (2010) Kevin A Schulman et al. NATURE BIOTECHNOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarker-adaptive clinical trial designs
- (2010) Boris Freidlin et al. PHARMACOGENOMICS
- Accumulation of driver and passenger mutations during tumor progression
- (2010) I. Bozic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of the Microenvironment in Mammary Gland Development and Cancer
- (2010) K. Polyak et al. Cold Spring Harbor Perspectives in Biology
- Mutational Heterogeneity in Human Cancers: Origin and Consequences
- (2009) Jesse J. Salk et al. Annual Review of Pathology-Mechanisms of Disease
- Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
- (2009) S. J. Horning et al. BLOOD
- Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy
- (2009) Richard A. Schwarz et al. CANCER
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
- (2009) B. Zhao et al. JOURNAL OF NUCLEAR MEDICINE
- Perspectives on the development of imatinib and the future of cancer research
- (2009) Brian J Druker NATURE MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective
- (2008) Shashi Amur et al. Biomarkers in Medicine
- Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
- (2008) Jeffrey Peppercorn et al. CANCER INVESTIGATION
- Randomized Phase III Clinical Trial Designs for Targeted Agents
- (2008) A. Hoering et al. CLINICAL CANCER RESEARCH
- Optimising the design of phase II oncology trials: The importance of randomisation
- (2008) Mark J. Ratain et al. EUROPEAN JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
- (2008) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Development and validation of biomarker classifiers for treatment selection
- (2007) Richard Simon JOURNAL OF STATISTICAL PLANNING AND INFERENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started